1. Search Result

Search Result

Results for "1257628-77-5" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-15666
    GZD824

    HQP1351

    Bcr-Abl Cancer
    GZD824 (HQP1351) is an orally bioavailable pan-Bcr-Abl inhibitor with potency against a wide range of Bcr-Abl mutants and the native enzyme (IC50=0.34 nM). GZD824 has antitumor activity.